CFO Scott Dalgleish departs April 29; enters consulting pact through May 31, 2022

Oncology Institute, Inc.

CFO Scott Dalgleish's last employment date was April 29, 2022; consulting agreement effective April 30 to May 31, 2022.
Consulting agreement allows continued vesting of up to 15,183 stock options; exercise period extended to Dec 31, 2022.
Separation and consulting terms described as ordinary course transition; no replacement named.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Scott Dalgleish

Chief Financial Officer

TOI · Oncology Institute, Inc.

Effective: 2022-04-29
Filed: May 5, 2022, 7:59 PM ET

Mr. Dalgleish’s last date of employment with the Company was April 29, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Dalgleish departed as Chief Financial Officer at Oncology Institute, Inc..

Action: departed
Role: Chief Financial Officer

Exact text from the filing

Mr. Dalgleish’s last date of employment with the Company was April 29, 2022.

View on SEC.gov

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-012714

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.